| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 3,530 | 3,574 | 03.03. | |
| 3,530 | 3,574 | 03.03. |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | Adverum launches phase 3 trial for wet AMD gene therapy | ||
| Mo | Adverum Biotechnologies, Inc.: Adverum Biotechnologies Initiates ARTEMIS Phase 3 Study Evaluating Ixo-vec for Wet AMD | ||
| Fr | Adverum Biotechnologies, Inc.: Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | REDWOOD CITY, Calif., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the Compensation Committee of Adverum's Board of Directors granted inducement... ► Artikel lesen | |
| Do | Adverum Biotechnologies, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| 19.12.24 | Adverum Biotechnologies, Inc. - S-8, Securities to be offered to employees in employee benefit plans |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 20.03.24 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 20.03.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 20.03.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 20.03.2024ISIN NameCA69842E2050 PANGENOMIC... ► Artikel lesen | |
| 14.03.24 | BowFlex Inc. assigned BFXXQ symbol on OTC Market | VANCOUVER, Wash.--(BUSINESS WIRE)--BowFlex Inc. ("BowFlex" or "the Company") announced that its Common Stock has been assigned the symbol "BFXXQ" with respect to quotations on the over-the-counter... ► Artikel lesen | |
| 05.03.24 | NYSE to Commence Delisting Proceedings Against BowFlex Inc. (BFX) | NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange ("NYSE", the "Exchange") announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the common stock... ► Artikel lesen | |
| 05.03.24 | XFRA DF3: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILBOWFLEX INC. DF3... ► Artikel lesen | |
| 05.03.24 | BowFlex Inc. Files for Voluntary Chapter 11 Protection and Reaches Stalking Horse Agreement to Facilitate Sale | VANCOUVER, Wash.--(BUSINESS WIRE)--BowFlex Inc. (NYSE: BFX) ("BowFlex" or "the Company") today announced that it has entered into a purchase agreement with Johnson Health Tech Retail, Inc. (the "Stalking... ► Artikel lesen |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Finnair's Annual Report 2024 has been published | ||
| Fr | Notice to Annual General Meeting of Finnair Plc | ||
| 14.02. | Finnair-Finanzvorstand Kristian Pullola tritt im August zurück | ||
| 14.02. | Finnair CFO Kristian Pullola to step down in August | ||
| 14.02. | Finnair Plc: Finnair's CFO Kristian Pullola to leave Finnair latest in August | Finnair Plc Stock Exchange Release 14 February 2025 at 9:00 a.m. EET
Kristian Pullola, Finnair's CFO, has announced that he will leave the company.
"Kristian and his team... ► Artikel lesen |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 30.01. | PanGenomic Health Inc.: PanGenomic Health Announces Repricing of Outstanding Warrants | ||
| 30.01. | Pangenomic Health Inc (3): Pangenomic slashes warrant exercise price to 17 cents | ||
| 11.01. | PanGenomic Health Inc.: PanGenomic Health Closes Private Placement Offering for Cash Proceeds and to Settle Indebtedness Totalling $750,000 | ||
| 09.01. | Pangenomic Health Inc (3): Pangenomic Health to slash warrant exercise price | ||
| 09.01. | PanGenomic Health Inc.: PanGenomic Health Announces Intention to Reprice Outstanding Warrants |
| Unternehmen / Aktien | Kurs | % |
|---|---|---|
| ADVERUM BIOTECHNOLOGIES INC | 3,880 | -6,73 % |
| BOWFLEX INC | 0,126 | 0,00 % |
| FINNAIR OYJ | 3,518 | -2,39 % |
| PANGENOMIC HEALTH INC | 0,174 | -1,19 % |
